EUVIMEDEUVIMED entdecken
Multizentrische Studie

Preoperative predictors of early recurrence after neoadjuvant gemcitabine plus S-1 in resectable pancreatic cancer: a multicenter study

Yoshihiro Shirai, Ryoga Hamura, Masashi Tsunematsu, Takeshi Gocho, Taro Sakamoto, Shinji Onda, Yoshiaki Tanji, Norimitsu Okui, Michinori Matsumoto, Kenei Furukawa, Koichiro Haruki, Toru Ikegami

Surgery Today · 2026-11 · 56 (11) · 2692-2700

DOI: 10.1007/s00595-026-03416-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Surgery Today, online erschienen am 13.07.2026. Verfasst von Yoshihiro Shirai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, …. Hauptthemen laut MEDLINE: Deoxycytidine, Tegafur, Oxonic Acid, Pancreatic Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidineTegafurOxonic AcidPancreatic NeoplasmsNeoadjuvant TherapyNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Pancreatic DuctalHumansGemcitabineDrug CombinationsRetrospective StudiesPancreatectomyCA-19-9 AntigenFemalePrognosisMaleAgedMiddle AgedDisease ProgressionTime FactorsPreoperative PeriodAged, 80 and over

Stichwörter der Autor:innen

Early recurrenceGemcitabine and S-1Neoadjuvant chemotherapyPancreatic cancerPancreatic resection

Substanzen

GemcitabineDeoxycytidineTegafurOxonic AcidDrug CombinationsS 1 (combination)CA-19-9 Antigen

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan. shirai@jikei.ac.jp.
  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan.
  • Department of Gastrointestinal Surgery, Saku General Hospital Advanced Care Center, Nagano, Japan.
  • Department of Surgery, The Jikei University West Medical Center, Tokyo, Japan.
  • Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Shirai, Y., Hamura, R., Tsunematsu, M., Gocho, T., Sakamoto, T., Onda, S., Tanji, Y., Okui, N., Matsumoto, M., Furukawa, K., Haruki, K., & Ikegami, T. (2026). Preoperative predictors of early recurrence after neoadjuvant gemcitabine plus S-1 in resectable pancreatic cancer: a multicenter study. Surgery Today, 56(11), 2692-2700. https://doi.org/10.1007/s00595-026-03416-8

Vancouver

Shirai Y, Hamura R, Tsunematsu M, Gocho T, Sakamoto T, Onda S, et al. Preoperative predictors of early recurrence after neoadjuvant gemcitabine plus S-1 in resectable pancreatic cancer: a multicenter study. Surgery Today. 2026;56(11):2692-2700. doi:10.1007/s00595-026-03416-8

BibTeX
@article{Shirai2026,
  author = {Shirai, Yoshihiro and Hamura, Ryoga and Tsunematsu, Masashi and Gocho, Takeshi and Sakamoto, Taro and Onda, Shinji and Tanji, Yoshiaki and Okui, Norimitsu and Matsumoto, Michinori and Furukawa, Kenei and Haruki, Koichiro and Ikegami, Toru},
  title = {Preoperative predictors of early recurrence after neoadjuvant gemcitabine plus S-1 in resectable pancreatic cancer: a multicenter study},
  journal = {Surgery Today},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {2692--2700},
  doi = {10.1007/s00595-026-03416-8}
}
Kostenlos starten →